Intra-Assay Performance Characteristics of Five Assays for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma
|
|
- Felicia McDaniel
- 5 years ago
- Views:
Transcription
1 JOURNAL OF CLINICAL MICROBIOLOGY, Mar. 1998, p Vol. 36, No /98/$ Copyright 1998, American Society for Microbiology Intra-Assay Performance Characteristics of Five Assays for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma HSIANG JU LIN, 1 LOUISE PEDNEAULT, 2 AND F. BLAINE HOLLINGER 1 * Division of Molecular Virology, Baylor College of Medicine, Houston, Texas, 1 and Antiviral Clinical Research Department, Bristol-Myers Squibb Pharmaceutical Research Institute, Wallingford, Connecticut 2 Received 23 June 1997/Returned for modification 7 November 1997/Accepted 1 December 1997 Three kits ( human immunodeficiency virus type 1 [HIV-1] Monitor, Chiron enhancedsensitivity bdna, and Organon Teknika NASBA HIV-1 QT) and two in-house assays (from National Genetics Institute and Baylor College of Medicine) were compared with a blinded panel. The results were evaluated as to intra-assay sensitivity, precision, and ability to detect differences in a dilution series. The quantification in plasma of human immunodeficiency virus type 1 (HIV-1) RNA is a useful test for predicting clinical outcome, evaluating disease progression, and monitoring the effect of antiretroviral treatment on HIV-1-infected patients (6, 9). The primary reason for undertaking this project was to evaluate the performance of selected methodologies or laboratories for monitoring the effect of antiretroviral therapy on HIV-1 viral load in clinical research. Three manufacturers of HIV-1 RNA kits and an independent laboratory agreed to participate in a single round of proficiency testing on a panel of Item Standards (Source: kit or in-house) Sample volume; sample preparation Amplification Chiron ES-bDNA External standards (kit): singlestranded DNA encoding gag and pol genes 1.0 ml, in duplicate; sedimentation of HIV-1 at 23,500 g/1 h, protease K digestion Signal amplification by means of hybridization of target region to probe, preamplifier, and bdna molecules TABLE 1. Methods employed for quantification of HIV-1 RNA NGI (in-house) External standards (inhouse): dilution series prepared from pooled HIV-1-positive sera and plasma 200 l; extraction with guanidinium thiocyanate-phenol-chloroform, alcohol precipitation cdna synthesis with random hexamers, PCR with four different cycle numbers with primers SK38 and SK39 or SK145 and SK431 plasma specimens. The laboratories performing the tests were chosen by the manufacturers. Enhanced-sensitivity bdna assays (ES-bDNA) were performed at the Chiron Reference Testing Laboratory (Emeryville, Calif.), tests were carried out at Novum, Inc. (Pittsburgh, Pa.), and NASBA (nucleic acid sequence-based amplification) HIV-1 QT assays were performed at Advanced Bioscience Laboratories, Inc. (Kensington, Md.). National Genetics Institute, or NGI (Culver City, Calif.), an established independent laboratory, used its in-house method. Because the panel samples were pre- Parameters for: Internal standard (kit): poly(a)- linked RNA containing conserved and rearranged sequences within the gag region 200 l; precipitation from guanidinium thiocyanate reagent, isopropanol wash Coamplification of standards and sample HIV-1 RNA by means of RT-PCR with SK462 and SK431 Organon Teknika NASBA HIV-1 QT Internal standards (kit): 1,500-nucleotide RNA homologous to the gag/ pol region, modified over a 20-nucleotide sequence 100 l; lysis in guanidinium thiocyanate reagent, adsorption to activated silica Coamplification of standards and sample by means of reverse transcriptase-, T7 polymerase- and RNase H-mediated reactions with primers conjugated to T7 promoter BCM (in-house) External standards (in-house): dilution series prepared from plasma spiked with strain HXB3 virions 140 l; spin column preparation with a commercial kit RT-PCR with primers SK38 and 5 biotinylated SK39 Detection Chemiluminescence Scanning densitometry Spectrophotometry Electrochemiluminescence Chemiluminescence * Corresponding author. Mailing address: Division of Molecular Virology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX Phone: (713) Fax: (713) blaineh@bcm.tmc.edu. Present address: Glaxo Wellcome, Inc., Research Triangle Park, NC
2 836 NOTES J. CLIN. MICROBIOL. TABLE 2. Quantification of HIV-1 RNA in 32 plasma specimens by five different methods Nominal no. of estimated HIV-1 RNA copies/ml a Chiron ESbDNA NGI (in-house) No. of HIV-1 RNA copies/ml estimated by b : BCM (in-house) Organon Teknika NASBA HIV-1 QT 2,000,000 ( 1,600,000) 1,300,000 2,050,000 (958,023) (19,000,000) 2,000,000 ( 1,600,000) 1,100,000 2,450,000 (882,538) 8,800,000 1,000,000 1,050, ,000 1,860,000 (836,158) 4,900,000 1,000,000 1,172, ,000 1,350, ,264 5,300, , , , , ,052 4,400, , , , ,000 (1,291,354) 3,700, , ,500 85, , ,356 1,400, , , , , , ,000 65,000 82,060 75,000 69, ,522 1,100,000 65,000 79,950 75, ,000 60, ,000 65,000 81,260 45,000 42,500 79, ,000 13,000 19,200 10,000 5,475 16, ,000 13,000 14,360 10,000 17,250 55, ,000 13,000 10,950 9,000 13,300 48, ,000 6,500 5,260 6,000 8,350 7,498 66,000 6,500 6,030 6,500 5,425 10,188 91,000 6,500 6,022 6,000 9,100 8,187 1,000,000 1, ,500 1,630 5,982 5,300 1,300 1, ,000 1,321 13,000 1, ,400 1,631 11, ,162 7, ( 500) ,911 8, ( 500) 500 1,200 (206) 12, ( 500) 300 ( 500) 421 ( 4,000) 130 ( 500) 150 ( 500) (123) ( 4,000) 130 ( 500) 200 ( 500) (221) ( 4,000) 65 ( 500) 200 ( 500) (341) ( 4,000) 65 ( 500) 150 ( 500) (188) ( 4,000) a As defined by standards produced at BCM. b The dynamic ranges of the assays claimed by the manufacturers or laboratories were as follows (in copies per milliliter): for ES-bDNA, 500 to ; for NGI, 100 to ; for BCM, 500 to ; for Roche, 400 to ; for NASBA, 4,000 to Reported results that fell above or below the claimed dynamic range are in parentheses. pared at the Center for AIDS Research Virology Core Facility at Baylor College of Medicine (BCM), we have also included in this report the results obtained with the in-house method that was used to establish their nominal concentrations. Summarized in Table 1 are the differences among the five assays. The ES-bDNA assay for HIV-1 RNA is a secondgeneration assay developed by the Chiron Corporation (Emeryville, Calif.) and incorporates changes in probe design and reagent composition (3). The distinctive feature of the NGI in-house assay was the use of four different numbers of PCR cycles (1). The AMPLICOR kit, manufactured by Roche Molecular Systems (Branchburg, N.J.), employed Thermus thermophilus polymerase, a recombinant enzyme capable of carrying out both reverse transcription (RT) and PCR (7). Assays based on NASBA technology developed by Organon Teknika (Durham, N.C.) were carried out under isothermal conditions and resulted in an RNA amplification product (11). The BCM method employed the Qiagen viral RNA kit (Santa Clarita, Calif.) for sample preparation and chemiluminescence assay of PCR products (Digene Diagnostics, Inc., Silver Spring, Md.) (5). HIV-1 standards and panel samples were prepared with normal acid-citrate-dextrose (ACD) plasma from individual blood donors who tested negative for anti-hiv-1, anti-hiv-2, anti-hepatitis B core, hepatitis B surface antigen, anti-hepatitis C virus, and anti-human T-cell leukemia virus type 1 (The Gulf Coast Regional Blood Center, Houston, Tex.). The primary standard was prepared by spiking negative plasma with supernatant fluid from a coculture of peripheral blood mononuclear cells from an HIV-1-infected patient (4). The secondary standard and panel samples were prepared by spiking negative plasma with HIV-1 strain HXB3 (5). Calibration of the secondary standards against the primary standard was based on 10 observations performed in five separate experiments with a between-runs coefficient of variation (CV) of 11.8%. The panel consisted of duplicate samples at , , 500,000, 130,000, and 65 HIV-1 RNA copies per ml; triplicate samples at 65,000, 13,000, 6,500, 1,300, 650, and 130 HIV-1 RNA copies per ml; and four samples of negative plasma. Aliquoting of samples was performed under optimal conditions to ensure sample uniformity. Specimens were shipped to testing sites on dry ice, and testing was performed in a blinded fashion at all sites, including the BCM laboratory. Presented in Table 2 are the results of HIV-1 RNA quantification for each sample as reported by the testing sites, compared with the nominal HIV-1 RNA concentrations. In comparisons of those results that fell within the dynamic range claimed for each method (listed in a footnote to the table), the differences between the means of results for replicate samples
3 VOL. 36, 1998 NOTES 837 FIG. 1. Linearity of HIV-1 RNA estimates performed on serially diluted spiked specimens by different assay methods. Assays employed were ES-bDNA, NGI, BCM, AMPLICOR, and NASBA HIV-1 QT. The straight diagonal line represents the equivalence of nominal and estimated HIV-1 RNA concentrations. Estimated concentrations for the dilution series that were obtained for a given assay are shown as connected points. Each point represents the mean of two or three estimates. If one or more of the reported results for a point fell outside the dynamic range of the assay, that point was omitted. Downloaded from that were obtained with the Chiron, NGI, BCM, and Roche assays generally fell within the same order of magnitude. The data in Table 2 were evaluated with respect to the ability of the assays to detect the known differences in HIV-1 RNA concentration present in the dilution series (Fig. 1). Nominal and estimated HIV-1 RNA concentrations were expressed as logarithms to the base 10. For each method, the mean of the results for each group of two or three panel samples with the same nominal HIV-1 concentration was calculated and represented as a point in the appropriate panel in Fig. 1. Groups that contained results falling outside the claimed dynamic range were omitted. For example, the ES-bDNA assay results for the three samples with 500 nominal HIV-1 RNA copies per ml and two samples with nominal copy numbers of were omitted. If an assay method correctly estimated the relationship of the various samples in the dilution series, a loglog plot of the estimated mean HIV-1 RNA concentrations against the nominal concentrations should produce a straight line having the same slope as the line of equivalence, shown in each panel as a diagonal straight line. The data set exhibiting the closest approximation of a straight line parallel to the line of equivalence was obtained by ES-bDNA. With perfect accuracy, the line representing the assay results should fall on the line of equivalence. This criterion must be applied with discretion, since the nominal concentrations of the panel samples are at best only estimates of an unknown value, the true HIV-1 RNA concentration. The results obtained with the Chiron, NGI, BCM, and Roche assays fell closest to the line of equivalence. These four assays provided estimates of HIV-1 RNA concentrations that generally agreed with each other and with the nominal concentrations of the BCM standards. In this sense, these assays were accurate. The slope of the line for the NASBA test also paralleled the line of equivalence but was displaced from it by approximately one log 10. The performance characteristics of the five assays are summarized in Table 3. The calculations of correlation, CV, and standard deviation (SD) were based solely on those results that fell within the claimed dynamic ranges. Correlation between the observed and nominal concentrations was close to for all five assays, although the results obtained by the NASBA assay were consistently higher. Intra-assay precision was expressed by the CV and as the logarithm of the SD to the base 10 (log 10 SD), a calculation that conveniently allowed comparison of SDs when the range of values covered several orders of magnitude. The ES-bDNA assay showed the smallest mean CV. An intra-assay SD of 0.15 to 0.20 log 10 RNA copies per ml is required in order to achieve the degree of precision that will provide 90% power to detect a fivefold difference in RNA concentration between two samples (12). The ES-bDNA, NGI, and BCM assays achieved this degree of precision. The duplicate log 10 SD was lower than the triplicate log 10 SD for all methods. This result was attributable to the composition of the panel. Samples tested in duplicate were preponderantly those with high HIV-1 RNA concentrations, while samples tested in triplicate were those with lower concentrations. Of the five assays, the ES-bDNA assay showed the highest overall intraassay precision, with a log 10 SD of to HIV-1-negative samples were correctly identified in all five assays, and no false positives were found; thus, the specificity was 100% for all five methods. It was demonstrated in the on September 17, 2018 by guest
4 838 NOTES J. CLIN. MICROBIOL. TABLE 3. Intra-assay performance characteristics of five methods for quantification of plasma HIV-1 RNA Performance characteristic Chiron ES-bDNA NGI (in-house) BCM (in-house) Correlation with nominal concentrations (no. of pairs) Organon Teknika NASBA HIV-1 QT (19) (28) (23) (16) (21) Mean CV (%) CV (range) % % % % % Log 10 SD: Duplicate Triplicate False-positive results (no. of results/total) experiment shown in Fig. 1 that there was little or no difference between the nominal HIV-1 RNA concentrations and the estimates of HIV-1 RNA concentration obtained by the Chiron, NGI, BCM, and Roche methods. It was thus possible to compare the dynamic range claimed for each of these four methods to the observed lower and upper limits of detection, abbreviated L and U, respectively. The observed L for ES-bDNA was higher than the claimed L; the observed H was consistent with the claimed H. NGI s observed L and U exceeded its claimed dynamic range, while BCM s observed L and U were consistent with its claims. The observed L and U of the AMPLICOR were both lower than those claimed by the manufacturer. This study underscores the importance of the use of welldefined standards for assigning nominal HIV-1 RNA concentrations to panel materials. In a previous comparison of the AMPLICOR and NASBA assays, both methods produced estimates below the nominal copy numbers (10). Compared to Monitor, NASBA has yielded higher estimates of HIV-1 RNA concentrations in two of three studies (2, 8, 10). This article describes the first performance comparison of ES-bDNA with other assays for HIV-1 RNA. Among the five laboratories that used ES-bDNA, the NGI assay, the BCM assay, Roche, and NASBA HIV-1 QT, the laboratories performing the first four tests named provided results that were generally consistent with each other. However, interlaboratory variation with the same kit is known to occur and may be greater than that which occurs with different kits (12). In other evaluations, the NASBA assay has performed well (2, 8, 10). The reason for the approximately 10- fold-higher values provided by the NASBA assay in the present study is being investigated. This event appears to be isolated, since many laboratories have successfully adopted the NASBA method (12). In our opinion, the laboratory may be more important than the assay method in the selection of a testing site for clinical trials. We thank the following persons for their cooperation: John Todd 0/4 0/4 0/4 0/4 0/4 Lower limit of detection (L) a : Claimed ,000 Observed 650 L 1, L Not evaluated Upper limit of detection (U) a : Claimed Observed U U U U Not evaluated a HIV-1 RNA copies/ml. and Pam Johnson, Chiron Corporation; Jay Weiss, Andrew J. Conrad, and Lawrence M. Blatt, NGI; Lisa Cosentino, Novum, Inc.; Beverly Dale, Roche Molecular Systems; Joe Romano, Advanced BioScience Laboratories, Inc.; and Michael Cronin, Stuart P. Geiger, and Richard J. Carroll, Organon Teknika Corp. The primary standard for HIV-1 RNA was prepared in the Eugene B. Casey Hepatitis & HIV Research Center and Diagnostic Laboratory at BCM in connection with a study (4) supported by a National Institutes of Health grant (AI-82517). Additional support was provided by the Center for AIDS Research (CFAR) Virology Core Facility grant (P30 A /05) awarded to BCM. REFERENCES 1. Conrad, A. J., P. Schmid, K. Syndulko, E. J. Singer, R. M. Nagra, J. J. Russell, and W. W. Tourtellotte Quantifying HIV-1 RNA using the polymerase chain reaction on cerebrospinal fluid and serum of seropositive individuals with and without neurologic abnormalities. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 10: Coste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J.-P. Vendrell, E. Delapporte, and M. Segondy Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type 1 RNA in plasma. J. Med. Virol. 50: Kern, D., M. Collins, T. Fultz, J. Detmer, S. Hamren, J. K. Peterkin, P. Sheridan, M. Urdea, R. White, T. Yeghiazarian, and J. Todd An enhanced-sensitivity branched-dna assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34: Lin, H. J., L. E. Myers, B. Yen-Lieberman, F. B. Hollinger, D. Henrard, C. J. Hooper, R. Kokka, S. Kwok, S. Rasheed, M. Vahey, M. A. Winters, L. J. McQuay, P. L. Nara, P. Reichelderfer, R. W. Coombs, and J. B. Jackson Multicenter evaluation of quantification methods for plasma human immunodeficiency virus type 1 RNA. J. Infect. Dis. 170: Lin, H. J., T. Tanwandee, and F. B. Hollinger Improved methods for quantification of human immunodeficiency virus type 1 (HIV-1) RNA and hepatitis C virus (HCV) RNA in blood using spin column technology and chemiluminescent assays of PCR products. J. Med. Virol. 51: Mellors, J. W., C. R. Rinaldo, Jr., P. Gupta, R. M. White, J. A. Todd, and L. A. Kingsley Prognosis in HIV-1 infection predicted by quantity of virus in plasma. Science 272: Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32: Revets, H., D. Marissens, S. De Wit, P. Lacor, N. Clumeck, S. Lauwers, and G. Zissis Comparative evaluation of NASBA HIV-1 RNA QT, AMPLICOR-HIV Monitor, and QUANTIPLEX HIV RNA assay, three
5 VOL. 36, 1998 NOTES 839 methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34: Saag, M. S., M. Holodniy, D. R. Kuritzkes, W. A. O Brien, R. Coombs, M. E. Poscher, D. M. Jacobsen, G. M. Shaw, D. D. Richman, and P. A. Volderbing HIV viral load markers in clinical practice. Nat. Med. 2: Schuurman, R., D. Descamps, G. van Weverling, S. Kaye, J. Tijnagel, I. Williams, R. van Leeuwen, R. Tedder, C. A. Boucher, F. Brun-Vezinet, and C. Loveday Multicenter comparison of three commercial methods for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34: van Gemen, B., T. Kievits, R. Schukkink, D. van Strijp, L. T. Matek, R. Sooknanan, H. G. Huisman, and P. Lens Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods 43: Yen-Lieberman, B., D. Brambilla, B. Jackson, J. Bremer, R. Coombs, M. Cronin, S. Herman, D. Katzenstein, S. Leung, H. J. Lin, P. Palumbo, S. Rasheed, J. Todd, M. Vahey, and P. Reichelderfer Evaluation of a quality assurance program for quantitation of human immunodeficiency virus type 1 RNA in plasma by the AIDS Clinical Trials Group Virology Laboratories. J. Clin. Microbiol. 34:
Introduction: Table/Figure Descriptions:
Introduction: We have completed the analysis of your HIV RNA Validation Study. The validation plan was designed to verify the installation of an unmodified FDA-approved HIV RNA assay into your laboratory.
More informationStability of Human Immunodeficiency Virus RNA in Blood Specimens as Measured by a Commercial PCR-Based Assay
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1998, p. 493 498 Vol. 36, No. 2 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Stability of Human Immunodeficiency Virus RNA in Blood Specimens
More informationApplication of a Commercial Kit for Detection of PCR Products to Quantification of Human Immunodeficiency Virus Type 1 RNA and Proviral DNA
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1996, p. 329 333 Vol. 34, No. 2 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Application of a Commercial Kit for Detection of PCR Products
More informationReceived 24 April 1996/Returned for modification 10 July 1996/Accepted 9 August 1996
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1996, p. 2695 2701 Vol. 34, No. 11 0095-1137/96/$04.00 0 Copyright 1996, American Society for Microbiology Evaluation of a Quality Assurance Program for Quantitation
More informationReceived 6 January 1995/Returned for modification 23 February 1995/Accepted 13 March 1995
JOURNAL OF CLINICAL MICROBIOLOGY, June 1995, p. 1562 1566 Vol. 33, No. 6 0095-1137/95/$04.00 0 Copyright 1995, American Society for Microbiology Comparative Stabilities of Quantitative Human Immunodeficiency
More informationPerformance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0
Clinical Chemistry / EVALUATION OF QUANTITATIVE HEPATITIS C VIRUS ASSAY Performance Characteristics of the COBAS AMPLICOR Hepatitis C Virus MONITOR Test, Version 2.0 Maria Erali, MS, 1 Edward R. Ashwood,
More informationLaboratory for Clinical and Biological Studies, University of Miami Miller School of Medicine, Miami, FL, USA.
000000 00000 0000 000 00 0 bdna () 00000 0000 000 00 0 Nuclisens () 000 00 0 000000 00000 0000 000 00 0 Amplicor () Comparison of Amplicor HIV- monitor Test, NucliSens HIV- QT and bdna Versant HIV RNA
More informationTechnical Bulletin No. 162
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 162 cobas 6800 HCV Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations
More informationHIV-1 Viral Load Real Time (RG)
-1 Viral Load Real Time (RG) Real Time RT-PCR type 1 RNA quantification assay MSP Reg. pending Valdense 3616. 11700. Montevideo. Uruguay. phone (598) 2 336 83 01. Fax (598) 2 336 71 60. Info@atgen.com.uy
More informationEffects of Specimen Collection, Processing, and Storage Conditions on Stability of Human Immunodeficiency Virus Type 1 RNA Levels in Plasma
JOURNAL OF CLINICAL MICROBIOLOGY, Nov. 1997, p. 2886 2893 Vol. 35, No. 11 0095-1137/97/$04.00 0 Copyright 1997, American Society for Microbiology Effects of Specimen Collection, Processing, and Storage
More informationDATA SHEET. Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter calf thymus DNA.
Viral Load DNA >> Standard PCR standard 0 Copies Catalog Number: 1122 Lot Number: 150298 Release Category: A Provided: 500 µl of 5.6 mm Tris HCl, 4.4 mm Tris base, 0.05% sodium azide 0.1 mm EDTA, 5 mg/liter
More informationVQA Control SOP Version 4.0 Roche Amplicor HIV-1 DNA Test, v August 2007
1. PRINCIPLE 1.1. The Virology Quality Assurance (VQA) Laboratory provides external cell pellet controls for use in the validation of assays that detect HIV proviral DNA. 1.2. HIV seronegative peripheral
More informationComparison of Quantitative and Qualitative PCR Assays for Cytomegalovirus DNA in Plasma
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2001, p. 1334 1338 Vol. 39, No. 4 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.4.1334 1338.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationDepartment of Human Retrovirology, Academic Medical Center, University of Amsterdam, Amsterdam, 1 and Organon Teknika B.V., Boxtel, 2 The Netherlands
JOURNAL OF CLINICAL MICROBIOLOGY, June 1999, p. 1813 1818 Vol. 37, No. 6 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Design and Evaluation of a Human Immunodeficiency
More informationTechnical Bulletin No. 161
CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 161 cobas 6800 HIV-1 Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations
More informationOriginal Articles. Viral Load Test Reports. A Description of Content From a Sample of US Laboratories
Original Articles Viral Load Test Reports A Description of Content From a Sample of US Laboratories Diane P. Francis, MPH, MT(ASCP); K. Michael Peddecord, DrPH; Louise K. Hofherr, PhD; J. Rex Astles, PhD;
More informationArmored RNA Technology for Production of Ribonuclease- Resistant Viral RNA Controls and Standards
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 1998, p. 3590 3594 Vol. 36, No. 12 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Armored RNA Technology for Production
More informationPerformance Characteristics of the QUANTIPLEX HIV-1 RNA 3.0 Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma
REFERENCES CONTENT ALERTS Performance Characteristics of the QUANTIPLEX HIV-1 RNA 3.0 Assay for Detection and Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma Alejo Erice, Donald Brambilla,
More informationMolecular Diagnosis Future Directions
Molecular Diagnosis Future Directions Philip Cunningham NSW State Reference Laboratory for HIV/AIDS & Molecular Diagnostic Medicine Laboratory, SydPath St Vincent s Hospital Sydney Update on Molecular
More informationVQA HIV DNA Control SOP Version 5.0 HIV DNA Testing 13 March 2012
1. PRINCIPLE 1.1. The Virology Quality Assurance (VQA) Laboratory provides external cell pellet controls for use in the validation of assays that detect HIV proviral DNA. 1.2. HIV seronegative peripheral
More informationUltrasensitive Reverse Transcription-PCR Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 1998, p. 2964 2969 Vol. 36, No. 10 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Ultrasensitive Reverse Transcription-PCR
More informationAlthough the public s awareness of infection with the
Results of a Physician Survey on Ordering Viral Load Testing Opportunity for Laboratory Consultation Louise K. Hofherr, PhD; Diane P. Francis, MPH, MT(ASCP); J. Rex Astles, PhD; William O. Schalla, MS
More informationQuantitation of Human Immunodeficiency Virus Type 1 RNA in Different Biological Compartments
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2000, p. 1414 1418 Vol. 38, No. 4 0095-1137/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. Quantitation of Human Immunodeficiency
More informationPelagia Research Library. European Journal of Experimental Biology, 2015, 5(10):1-5
Available online at www.pelagiaresearchlibrary.com European Journal of Experimental Biology, 2015, 5(10):1-5 ISSN: 2248 9215 CODEN (USA): EJEBAU Molecular diagnosis of human immuno deficiency virus (HIV)
More informationCALIBRATION OF ANALYTICAL STANDARDS FOR HBV-DNA, HCV-RNA AND HIV-1 RNA IN GENOME COPIES BY A REFERENCE METHOD
CALIBRATION OF ANALYTICAL STANDARDS FOR HBV-DNA, HCV-RNA AND HIV-1 RNA IN GENOME COPIES BY A REFERENCE METHOD AAJ van Drimmelen, E.R. Bax and W.G.V. Quint, BioQControl (BQC), Delft Diagnostic Laboratories
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationComparison of Quantitative HCV RNA Assays in Chronic Hepatitis C
MICROBIOLOGY AND INFECTIOUS DISEASE Original Article Comparison of Quantitative HCV RNA Assays in Chronic Hepatitis C SHERAJ JACOB, MD, DEBORAH BAUDY, ELIZABETH JONES, LIZHE XU, PhD, ANDREW MASON, MBBS,
More informationVARIATION IN MEASUREMENT OF HIV RNA VIRAL LOAD
VARIATION IN MEASUREMENT OF HIV RNA VIRAL LOAD SOURCES OF VARIATION (RANDOM VS SYSTEMATIC) MAGNITUDE OF EACH SOURCE CONSEQUENCES FOR CONFIDENCE LIMITS AROUND MEASUREMENTS AND CHANGES DATA FROM ROCHE HIV
More informationArmored Long RNA Controls or Standards for Branched DNA Assay for Detection of Human Immunodeficiency Virus Type 1
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2009, p. 2571 2576 Vol. 47, No. 8 0095-1137/09/$08.00 0 doi:10.1128/jcm.00232-09 Copyright 2009, American Society for Microbiology. All Rights Reserved. Armored Long
More informationGenotype Dependence of Hepatitis C Virus Load Measurement in Commercially Available Quantitative Assays
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 1999, p. 2525 2532 Vol. 37, No. 8 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Genotype Dependence of Hepatitis C
More informationExternal Quality Assessment Program for Qualitative and Quantitative Detection of Hepatitis C Virus RNA in Diagnostic Virology
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2002, p. 2973 2980 Vol. 40, No. 8 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.8.2973 2980.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationPapers. Clinical application of the Quantiplex HCV RNA 2.0 and Amplicor HCV Monitor assays for quantifying serum hepatitis C virus RNA
J Clin Pathol 1999;52:807 811 807 Papers Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical College Hospital, No 100, Shih-Chuan 1st Rd, Kaohsiung, Taiwan, Republic of China M-L
More informationSupplemental Materials and Methods Plasmids and viruses Quantitative Reverse Transcription PCR Generation of molecular standard for quantitative PCR
Supplemental Materials and Methods Plasmids and viruses To generate pseudotyped viruses, the previously described recombinant plasmids pnl4-3-δnef-gfp or pnl4-3-δ6-drgfp and a vector expressing HIV-1 X4
More informationFor purification of viral DNA and RNA from a wide range of sample materials
QIAamp virus kits For purification of viral DNA and RNA from a wide range of sample materials Automatable on QIAGEN s proven QIAamp Kits set the standard for purification of viral DNA and RNA. QIAamp virus
More informationUse of Multiple Competitors for Quantification of Human Immunodeficiency Virus Type 1 RNA in Plasma
JOURNAL OF CLINICAL MICROBIOLOGY, July 1998, p. 1864 1870 Vol. 36, No. 7 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Use of Multiple Competitors for Quantification
More informationWHO Prequalification of In Vitro Diagnostics PUBLIC REPORT. Product: Alere q HIV-1/2 Detect WHO reference number: PQDx
WHO Prequalification of In Vitro Diagnostics PUBLIC REPORT Product: Alere q HIV-1/2 Detect WHO reference number: PQDx 0226-032-00 Alere q HIV-1/2 Detect with product codes 270110050, 270110010 and 270300001,
More informationProposed 1 st IS for Hepatitis E Virus RNA WHO/BS/
www.pei.de Proposed 1 st IS for Hepatitis E Virus RNA WHO/BS/09.2126 S. Baylis, Division of Virology, Paul-Ehrlich-Institut, Langen, Germany SoGAT XXII 14 th -15 th April 2011, Rome, Italy Presented at:
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: COBAS AmpliPrep/COBAS TaqMan HIV-1 Test, version 2.0 (TaqMan 48) Number: PQDx 0126-046-00 Abstract The COBAS AmpliPrep/COBAS TaqMan
More informationSimple Solutions for Patient Monitoring. Maximum Flexibility 2 Configuration: 8 to 1000 viral load tests/day 2 Sample: Plasma/DBS
Simple Solutions for Patient Monitoring What is the interest of having a high level of sensitivity? Higher sensitivity means you are able to offer better patient monitoring, particularly in the low viral
More informationStrengths and Limitations of Commercial Tests for Hepatitis C Virus RNA Quantification
JOURNAL OF CLINICAL MICROBIOLOGY, Jan. 2004, p. 421 425 Vol. 42, No. 1 0095-1137/04/$08.00 0 DOI: 10.1128/JCM.42.1.421 425.2004 Copyright 2004, American Society for Microbiology. All Rights Reserved. Strengths
More informationDiagnostic Methods of HBV and HDV infections
Diagnostic Methods of HBV and HDV infections Zohreh Sharifi,ph.D Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine Hepatitis B-laboratory diagnosis Detection
More informationDiagnostic Methods of HBV infection. Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO)
Diagnostic Methods of HBV infection Zohreh Sharifi,ph.D of Virology Research center, Iranian Blood Transfusion Organization (IBTO) Hepatitis B-laboratory diagnosis Detection of HBV infection involves
More informationVerification and validation of diagnostic laboratory tests in clinical virology
Journal of Clinical Virology 40 (2007) 93 98 Review Verification and validation of diagnostic laboratory tests in clinical virology Holger F. Rabenau a,, Harald H. Kessler b, Marhild Kortenbusch a, Andreas
More informationHBV PUBLIC HEALTH IMPLICATIONS
جزايری دکتر سيد محمد آزمايشگاه ھپاتيت B -دانشکده بھداشت ويروس شناسی- گروه دانشگاه علوم پزشکی تھران کنگره ارتقا کيفيت- ١٣٩٢ HBV PUBLIC HEALTH IMPLICATIONS 2 billion people have been infected by HBV worldwide.
More informationSensitivity of the Procleix HIV-1/HCV Assay for Detection of Human Immunodeficiency Virus Type 1 and Hepatitis C Virus RNA in a High-Risk Population
JOURNAL OF CLINICAL MICROBIOLOGY, July 2002, p. 2387 2391 Vol. 40, No. 7 0095-1137/02/$04.00 0 DOI: 10.1128/JCM.40.7.2387 2391.2002 Copyright 2002, American Society for Microbiology. All Rights Reserved.
More informationW ith an estimated million people worldwide
141 ORIGINAL ARTICLE Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan C-Y Dai,
More informationPerformance of an automated system for quantification of hepatitis C virus RNA
Journal of Virological Methods 86 (2000) 55 60 www.elsevier.com/locate/jviromet Performance of an automated system for quantification of hepatitis C virus RNA Anne Marie Roque Afonso a, *, Josiane Didier
More informationTrends in molecular diagnostics
Trends in molecular diagnostics Detection of target genes of interest Quantification Infectious diseases HIV Hepatitis C & B TB / MAC Cytomegalovirus Herpes simplex Varicella zoster CT/GC HPV Profiling
More informationPhosphate buffered saline (PBS) for washing the cells TE buffer (nuclease-free) ph 7.5 for use with the PrimePCR Reverse Transcription Control Assay
Catalog # Description 172-5080 SingleShot Cell Lysis Kit, 100 x 50 µl reactions 172-5081 SingleShot Cell Lysis Kit, 500 x 50 µl reactions For research purposes only. Introduction The SingleShot Cell Lysis
More informationSYNOPSIS. Clinical Study Report AI Addendum #1. Open-label Dosing Phase
Name of Sponsor/Company: Bristol-Myers Squibb Name of Finished Product: Individual Study Table Referring to the Dossier (For National Authority Use Only) Name of Active Ingredient: Entecavir SYNOPSIS Clinical
More informationWHO Prequalification of Diagnostics Programme PUBLIC REPORT. Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx
WHO Prequalification of Diagnostics Programme PUBLIC REPORT Product: VERSANT HIV-1 RNA 1.0 Assay (kpcr) Number: PQDx 0115-041-00 Abstract The VERSANT HIV-1 RNA 1.0 Assay (kpcr) with product codes 10375763,
More informationSwitch from Signal Amplification to COBAS AmpliPrep/COBAS TaqMan 48: Is There a Need to Re-Baseline?
Switch from Signal Amplification to COBAS AmpliPrep/COBAS TaqMan 48: Is There a Need to Re-Baseline? MADHUCHHANDA CHOUDHARY, GLORIA CALDITO, JANICE M MATTHEWS-GREER ABSTRACT Background: Accurate quantitation
More informationFor Research Use Only Ver
INSTRUCTION MANUAL ZR Viral RNA Kit Catalog Nos. R1034 & R1035 Highlights Quick, 5-minute recovery of viral RNA from plasma, serum and other samples. Omits the use of organic denaturants and proteases.
More information(DNA) Real-time PCR. Exicycler 96 Rotor-Gene Q/6000 PCR
Real-Time (DNA) Real-time Exicycler 96 Rotor-Gene Q/6000 IU Mix1 Mix2 IU/μl IU/μl IU/μl IU/μl IU/μl IPC NTC C 1 Lot# 2 Freeze & thawing 1 MSDS: Material Safety Data Sheets (TaqMan Real-time ' FAM ' BHQ1
More informationOfficial Journal of the European Communities COMMISSION
16.5.2002 EN Official Journal of the European Communities L 131/17 COMMISSION COMMISSION DECISION of 7 May 2002 on common technical specifications for in vitro-diagnostic medical devices (notified under
More informationExperience with Standardisation of Blood Virology NAT. Clare Morris Division of Retrovirology National Institute for Biological Standards and Control
Experience with Standardisation of Blood Virology NAT Clare Morris Division of Retrovirology National Institute for Biological Standards and Control Background of Blood Virology Standardisation In the
More informationHepatitis C Virus (RNA)A
Hepatitis C Virus (RNA)A 2012 EQA Programme Final Report QAV994112 (HCVRNA12A) Professor Jacques Izopet Scientific Expert on behalf of QCMD Report authorised by the QCMD Executive in July 2012 A UKAS accredited
More informationCMV DNA Quantification Using an Automated Platform for Nucleic Acid Extraction and Real- time PCR Assay Set-up
JCM Accepts, published online ahead of print on 11 May 2011 J. Clin. Microbiol. doi:10.1128/jcm.00721-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationJuly VQAAB Minutes VQA Advisory Board (VQAAB) Members
To: cc: From: VQA Advisory Board (VQAAB) Members Mike Ussery Joe Fitzgibbon VQA Members Cheryl Jennings Date: 30 July 2010 Subject: VQAAB Conference Call Minutes (call dated 13 July 2010) Attendees: Voting:
More informationHigh Failure Rate of the ViroSeq HIV-1 Genotyping System for Drug Resistance Testing in Cameroon, a Country with Broad HIV-1 Genetic Diversity
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 2011, p. 1635 1641 Vol. 49, No. 4 0095-1137/11/$12.00 doi:10.1128/jcm.01478-10 Copyright 2011, American Society for Microbiology. All Rights Reserved. High Failure
More informationB19 Virus EQA Programme Final Report QAV (B19DNA14)
B19 Virus 2014 EQA Programme Final Report QAV034116 (B19DNA14) Prof. Hubert GM Niesters Scientific Expert on behalf of QCMD Report authorised by the QCMD Executive in July 2014 A UKAS accredited proficiency
More informationP0141 HBV 1000 copies/ml genotype reference panel
P0141 HBV 1000 copies/ml genotype reference panel P0141 The kit insert contains a detailed protocol and should be read carefully before testing the run control to ensure optimal performance Table of contents
More informationVIRAL TITER COUNTS. The best methods of measuring infectious lentiviral titer
VIRAL TITER COUNTS The best methods of measuring infectious lentiviral titer FLUORESCENCE CYCLES qpcr of Viral RNA SUMMARY Viral vectors are now routinely used for gene transduction in a wide variety of
More informationDiagnostic Testing for HIV Type 1 RNA in Seronegative Blood
Coagulation and Transfusion Medicine / DIAGNOSIS OF EARLY HIV INFECTION Diagnostic Testing for HIV Type 1 RNA in Seronegative Blood Detlef Ritter, MD, 1,2 James Taylor, 1 Richard Walkenbach, 3 Michael
More informationQUANTITATIVE HIV RNA (VIRAL LOAD)
CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS QUANTITATIVE HIV RNA (VIRAL LOAD) Policy Number: PDS - 008 Effective Date: October
More informationMicropathology Ltd. University of Warwick Science Park, Venture Centre, Sir William Lyons Road, Coventry CV4 7EZ
www.micropathology.com info@micropathology.com Micropathology Ltd Tel 24hrs: +44 (0) 24-76 323222 Fax / Ans: +44 (0) 24-76 - 323333 University of Warwick Science Park, Venture Centre, Sir William Lyons
More informationClinical Evaluation of an In-House Reverse Transcription-Competitive PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 1999, p. 333 338 Vol. 37, No. 2 0095-1137/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Clinical Evaluation of an In-House Reverse
More informationVirus Levels in Untreated African Infants Infected with Human Immunodeficiency Virus Type 1
1838 Virus Levels in Untreated African Infants Infected with Human Immunodeficiency Virus Type 1 Robert J. Biggar, 1 Michelle Janes, 4 Richard Pilon, 4 Paolo Miotti, 2 Taha E. T. Taha, 3 Robin Broadhead,
More informationQuantification of HBV, HCV genotype and HIV subtype panels
Quantification of HBV, HCV genotype and HIV subtype panels Harry van Drimmelen 1,2, Wim Quint 2, Nico Lelie 3 and the international NAT study group 1. Biologicals Quality Control, 2. DDL Diagnostic Laboratory,
More informationQuantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
CLINICAL MICROBIOLOGY REVIEWS, July 1998, p. 533 554 Vol. 11, No. 3 0893-8512/98/$04.00 0 Copyright 1998, American Society for Microbiology. All Rights Reserved. Quantitation of Cytomegalovirus: Methodologic
More informationRealLine HIV quantitative Str-Format
Instructions for use DETECTION AND QUANTIFICATION OF THE HUMAN IMMUNODEFICIENCY VIRUS RNA BY REAL TIME PCR Research Use Only (RUO) Attention! Please read the information about quantification process carefully!
More informationHuman diagnostics. Better be Sure: Quantify HDV & HBV viral load. RoboGene product family
Human diagnostics Better be Sure: Quantify HDV & HBV viral load. RoboGene product family 2 RoboGene Product Family Improved patient management: Standardized monitoring of HBV DNA and HDV RNA viral load.
More informationApplication of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma
Excerpt from MACS&more Vol 8 1/2004 Application of μmacs Streptavidin MicroBeads for the analysis of HIV-1 directly from patient plasma L. Davis Lupo and Salvatore T. Butera HIV and Retrovirology Branch,
More informationDEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA - UPDATE
DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA - UPDATE SoGAT Clinical Diagnostics III 12-13 January 2011, London Michael Chudy Julia Kreß Micha Nübling Paul-Ehrlich-Institut
More informationon May 2, 2018 by guest
JCM Accepts, published online ahead of print on 5 September 2012 J. Clin. Microbiol. doi:10.1128/jcm.01221-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 2 3 4 Title: Ten
More informationFrozen Master Mix Modification of Commercial Reverse-transcriptase PCR. for Detection of Influenza and Respiratory Syncytial Viruses
JCM Accepted Manuscript Posted Online 28 January 2015 J. Clin. Microbiol. doi:10.1128/jcm.03457-14 Copyright 2015, American Society for Microbiology. All Rights Reserved. 1 2 Frozen Master Mix Modification
More informationQUANTITATIVE HIV RNA (VIRAL LOAD)
CLINICAL GUIDELINES For use with the UnitedHealthcare Laboratory Benefit Management Program, administered by BeaconLBS QUANTITATIVE HIV RNA (VIRAL LOAD) Policy Number: PDS - 008 Effective Date: January
More informationLaboratories That Offer the Ultra-senstive PCR Test to Individuals
National AIDS Treatment Advocacy Project Laboratories That Offer the Ultra-senstive PCR Test to Individuals On July 14 and 15, 1997, the FDA held a public hearing to discuss using viral load as a primary
More informationRT-PCR DETECTION OF HIV IN REPUBLIC OF MACEDONIA
& RT-PCR DETECTION OF HIV IN REPUBLIC OF MACEDONIA Golubinka Bosevska¹*, Nikola Panovski², Eleni Dokić², Violeta Grunevska³ ¹ Republic Institute for Health Protection, 50 Divizija No 6, 1000 Skopje, Macedonia
More informationEfficient Extraction of Virus DNA by NucliSens Extractor Allows Sensitive Detection of Hepatitis B Virus by PCR
JOURNAL OF CLINICAL MICROBIOLOGY, Dec. 2001, p. 4339 4343 Vol. 39, No. 12 0095-1137/01/$04.00 0 DOI: 10.1128/JCM.39.12.4339 4343.2001 Copyright 2001, American Society for Microbiology. All Rights Reserved.
More informationPerformance of Version 2.0 of the Cobas AmpliPrep/Cobas TaqMan Real-Time PCR Assay for Hepatitis B Virus DNA Quantification
JOURNAL OF CLINICAL MICROBIOLOGY, Oct. 2010, p. 3641 3647 Vol. 48, No. 10 0095-1137/10/$12.00 doi:10.1128/jcm.01306-10 Copyright 2010, American Society for Microbiology. All Rights Reserved. Performance
More informationNew HIV Tests and Algorithm: A change we can believe in
New HIV Tests and Algorithm: A change we can believe in Esther Babady, PhD, D (ABMM) Memorial Sloan-Kettering Cancer Center New York, New York Learning Objectives After this presentation you should be
More informationBEIPH Final Report. EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011
BEIPH Final Report EQA Programme 2011 Chlamydia trachomatis (CTDNA11A) William G Mackay on behalf of QCMD and its Scientific Council April 2011 Not to be reproduced or quoted without permission of QCMD.
More information(DNA) Real-time PCR. Exicycler 96 Rotor-Gene Q/6000 PCR
Real-Time (DNA) Real-time Exicycler 96 Rotor-Gene Q/6000 IU Mix1 Mix2 IU/μl IU/μl IU/μl IU/μl IU/μl IPC NTC C 1 Lot# 2 Freeze & thawing 1 MSDS: Material Safety Data Sheets Real- (TaqMan time ' FAM ' BHQ1
More informationA Sensitive Branched DNA HIV-1 Signal Amplification Viral Load Assay with Single Day Turnaround
A Sensitive Branched DNA HIV-1 Signal Amplification Viral Load Assay with Single Day Turnaround Mark A. Baumeister, Nan Zhang, Hilda Beas, Jesse R. Brooks, Jesse A. Canchola, Carlo Cosenza, Felix Kleshik,
More informationPerformance evaluation of the new Roche COBAS AmpliPrep. COBAS TaqMan HIV-1 test version 2.0 for the quantification of HIV-1 RNA
JCM Accepts, published online ahead of print on 17 February 2010 J. Clin. Microbiol. doi:10.1128/jcm.01832-09 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All
More informationPanther has new prey
Raising the Bar for Performance Testing Panther has new prey The Aptima HIV-1 Quant Dx assay leads the hunt for HIV-1 diagnosis and viral load monitoring. Freedom to work the way you choose Run what assays
More informationPrinciples of HIV resistance testing and overview of assay performance characteristics
Principles of HIV resistance testing and overview of assay performance characteristics Douglas D Richman Antiviral Therapy 5: 27-31 Departments of Pathology and Medicine, San Diego VA Medical Center and
More informationInstructions for Use. RealStar Influenza Screen & Type RT-PCR Kit /2017 EN
Instructions for Use RealStar Influenza Screen & Type RT-PCR Kit 4.0 05/2017 EN RealStar Influenza Screen & Type RT-PCR Kit 4.0 For research use only! (RUO) 164003 INS-164000-EN-S01 96 05 2017 altona
More informationA Genotype-Independent Real-Time PCR Assay for Quantification of Hepatitis B Virus DNA
JOURNAL OF CLINICAL MICROBIOLOGY, Feb. 2007, p. 553 558 Vol. 45, No. 2 0095-1137/07/$08.00 0 doi:10.1128/jcm.00709-06 Copyright 2007, American Society for Microbiology. All Rights Reserved. A Genotype-Independent
More informationComparison of Three Roche HBV Viral Load Assay Formats
JCM Accepts, published online ahead of print on 25 April 2012 J. Clin. Microbiol. doi:10.1128/jcm.00746-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Title 2 3 4 5 6 7 8
More informationHEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS
HEPATITIS C VIRUS GENOTYPING IN CHRONIC HEPATITIS C PATIENTS I. Qattan Centres for Hepatology, Royal Free & University College Medical School, London V. Emery Department of Virology, Royal Free & University
More informationReceived 3 November 1997/Returned for modification 9 December 1997/Accepted 29 December 1997
JOURNAL OF CLINICAL MICROBIOLOGY, Apr. 1998, p. 1056 1063 Vol. 36, No. 4 0095-1137/98/$04.00 0 Copyright 1998, American Society for Microbiology Comparison of Culture- and Non-Culture-Based Methods for
More informationEffect of antiviral treatment on the shedding of HIV-1 in semen
Effect of antiviral treatment on the shedding of HIV-1 in semen Pietro L. Vernazza*, Bruce L. Gilliam, Markus Flepp, John R. Dyer, Andreas C. Frank*, Susan A. Fiscus, Myron S. Cohen and Joseph J. Eron
More informationMultilaboratory Evaluation of Real-Time PCR Tests for Hepatitis B Virus DNA Quantification
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2011, p. 2854 2858 Vol. 49, No. 8 0095-1137/11/$12.00 doi:10.1128/jcm.00471-11 Copyright 2011, American Society for Microbiology. All Rights Reserved. Multilaboratory
More informationProduct # Kit Components
3430 Schmon Parkway Thorold, ON, Canada L2V 4Y6 Phone: (905) 227-8848 Fax: (905) 227-1061 Email: techsupport@norgenbiotek.com Pneumocystis jirovecii PCR Kit Product # 42820 Product Insert Background Information
More informationHepatitis C Virus Genotype 2 may not be detected by the Cobas AmpliPrep/Cobas. TaqMan HCV Test, version 1.0
JCM Accepts, published online ahead of print on 25 September 2013 J. Clin. Microbiol. doi:10.1128/jcm.02102-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 Hepatitis C Virus
More informationEvaluation of the MagNA Pure LC Instrument for Extraction of Hepatitis C Virus RNA for the COBAS AMPLICOR Hepatitis C Virus Test, Version 2.
JOURNAL OF CLINICAL MICROBIOLOGY, Aug. 2003, p. 3503 3508 Vol. 41, No. 8 0095-1137/03/$08.00 0 DOI: 10.1128/JCM.41.8.3503 3508.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationAssays to Address Emerging Threats to Blood Safety
Assays to Address Emerging Threats to Blood Safety Jeffrey M. Linnen, Ph.D. Director, Product Development Gen-Probe Incorporated San Diego, CA The IPFA/PEI 17th Workshop on Surveillance and Screening of
More information